Targeting EGFR in melanoma – The sea of possibilities to overcome drug resistance-Reference-Cited by-同舟云学术

Targeting EGFR in melanoma – The sea of possibilities to overcome drug resistance

Published:2022-07 Issue:4 Volume:1877 Page:188754
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Pastwińska Joanna,Karaś Kaja,Karwaciak Iwona,Ratajewski Marcin

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference207 articles.

1. Cutaneous and ocular side-effects of PUVA photochemotherapy--a 10-year follow-up study;Abdullah;Clin. Exp. Dermatol.,1989

2. Malignant melanoma of the mucous membranes: a review of 119 cases;DeMatos;Ann. Surg. Oncol.,1998

3. Primary malignant melanoma of the meninges;Thornton;Clin. Neuropathol.,2022

4. Melanoma epidemiology and early detection in europe: diversity and disparities;Forsea;Dermatol. Pract. Concept.,2020

5. Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018;Memon;Lancet Reg. Heal. Eur.,2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways;Translational Oncology;2024-02

2. Global, Regional, and National Incidence Trend Analysis of Malignant Skin Melanoma Between 1990 and 2019, and Projections Until 2034;Cancer Control;2024-01

3. Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications;Cells;2023-12-25

4. 20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. Ferroptosis as a promising therapeutic strategy for melanoma;Frontiers in Pharmacology;2023-09-19